Alterity Therapeutics (ATHE) Research & Development (2015 - 2025)
Alterity Therapeutics' quarterly Research & Development came in at $4.3 million in Q4 2025, up 42.4% year-on-year from $3.0 million in Q4 2024, and up 42.4% quarter-over-quarter from $3.0 million in Q4 2024.
Alterity Therapeutics has reported Research & Development for 10 years, with the latest figure at $4.3 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 42.4% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $15.6 million (up 1.7% YoY), and the FY2025 full-year result was $9.2 million, down 100.0% from the prior year.
- Research & Development for Q4 2025 stood at $4.3 million, up from $3.0 million in the prior quarter.
- The five-year high for Research & Development was $4.3 million in Q4 2025, with the low at $3.0 million in Q4 2024.
- Average Research & Development over 5 years is $3.9 million, with a median of $4.1 million recorded in 2023.
- Year-over-year, Research & Development declined 26.77% in 2024 and soared 42.4% in 2025.
- Tracing ATHE's Research & Development over 5 years: stood at $4.1 million in 2021, then gained by 2.3% to $4.2 million in 2022, then declined by 0.23% to $4.1 million in 2023, then decreased by 26.77% to $3.0 million in 2024, then soared by 42.4% to $4.3 million in 2025.
- The last three Research & Development figures came in at $4.3 million (Q4 2025), $3.0 million (Q4 2024), and $4.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 343.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.32 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 4.06 Mn |
| Dec 31, 2019 | -3.93 Mn |
| Dec 31, 2018 | -4.23 Mn |
| Dec 31, 2017 | -1.76 Mn |
| Dec 31, 2016 | 2.87 Mn |
| Dec 31, 2015 | -7.08 Mn |